1. Alternative lengthening of telomeres in pancreatic neuroendocrine tumors is associated with more aggressive clinicopathologic features and increased risk of recurrence. (2021) Authors: Gudmundsdottir, H.; Graham, R.P.; Smoot, R.L.; Truty, M.J.; Kendrick, M.L.; Halfdanarson, T.R.; Cleary, S.P. Journal: HPB Issue: Volume 23(2021)Supplement 2 Page Start: S478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Is Pancreatectomy with Vascular Resection and Reconstruction for Locally Advanced Pancreatic Neuroendocrine Tumors Safe?. (2022) Authors: Gudmundsdottir, H.; Tomlinson, J.L.; Graham, R.P.; Smoot, R.L.; Truty, M.J.; Kendrick, M.L.; Nagorney, D.M.; Halfdanarson, T.R.; Habermann, E.B.; Cleary, S.P. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S350 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Surgical Outcomes after Synchronous versus Metachronous Hepatectomy in Patients with Metastatic Pancreatic Neuroendocrine Tumors. (2022) Authors: Gudmundsdottir, H.; Pery, R.; Graham, R.P.; Smoot, R.L.; Truty, M.J.; Kendrick, M.L.; Nagorney, D.M.; Halfdanarson, T.R.; Habermann, E.B.; Cleary, S.P. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗